The role of cannabis in pain management among people living with HIV who use drugs: A qualitative study Koharu Loulou Chayama, Jenna Valleriani, Cara Ng, Rebecca Haines-Saah, Rielle Capler, M.-J. Milloy, Will Small, Ryan McNeil Introduction People living with HIV who use drugs commonly experience chronic pain and often use illicit opioids to manage pain. […]
Read More
Case Study of Hair Regrowth with Topical Cannabidiol (CBD) Gregory L. Smith and John Satino Abstract Introduction: Discovered in the 1990s, the endocannabinoid system (ECS) is involved with maintaining cellular homeostasis by downregulating the damaging inflammatory response and upregulating regenerative processes. Cannabidiol (CBD) has novel therapeutic effects, different from and synergistic with current hair regrowth therapies. CBD is […]
Read More
Regulating Cannabis: Towards a Unified Market Including analysis of hundreds of pages of government documents, almost 1000 media articles, and interviews in the field with over 30 senior government officials, industry executives, and front-line public health representatives, together with over 800 academic references, this meticulously researched book is the definitive account of real-world cannabis […]
Read More
Daily cannabis consumers’ driving performance not significantly impacted according to simulation study Ashley Brooks-Russell, Tim Brown, Kyle Friedman, Julia Wrobel, John Schwarz, Gregory Dooley, Karen A Ryall, Benjamin Steinhart, Elise Amioka, Gary Milavetz, George Sam Wang, Michael J Kosnett Abstract Objective: Daily cannabis users develop tolerance to some drug effects, but the extent to which this […]
Read More
Medical cannabis in the UK: From principle to practice Anne Katrin Schlag, David S Baldwin, Michael Barnes, Steve Bazire, Rachel Coathup, H Valerie Curran, Rupert McShane, Lawrence D Phillips, Ilina Singh, David J Nutt Background: In the UK, medical cannabis was approved in November 2018, leading many patients to believe that the medicine would […]
Read More
Exploring the use of cannabis as a substitute for prescription drugs in a convenience sample Sinikka L. Kvamme, Michael M. Pedersen, Kristine Rømer Thomsen & Birgitte Thylstrup Background The use of cannabis as medicine (CaM) both prescribed and non-prescribed has increased markedly in the last decade, mirrored in a global shift in cannabis policy […]
Read More
Proportion of Prescribed Conditions & Latest Patient Approval Numbers To date, the TGA has approved SAS applications including, but not limited to, the following indications: chemotherapy-induced nausea and vomiting refractory paediatric epilepsy palliative care indications cancer pain neuropathic pain spasticity from neurological conditions anorexia and wasting associated with chronic illness (such as cancer) A break […]
Read More
Tasmania Emerges Into the Light on Medical Cannabis – Doctors Allowed to Prescribe Medicinal cannabis products are products lawfully manufactured and prescribed for a therapeutic purpose which are either derived from legally cultivated cannabis plants or synthetically made cannabinoid substances but are not included on the Australian Register of Therapeutic Goods (ARTG) ‘unregistered’. There are […]
Read More
Proudly Supporting NAIDOC – Cultural & Creative Achievements of Aboriginals & Torres Strait People NAIDOC Week celebrations are held across Australia each July to celebrate the history, culture and achievements of Aboriginal and Torres Strait Islander peoples. NAIDOC is celebrated not only in Indigenous communities, but by Australians from all walks of life. The week […]
Read More
The impact of cannabis use on male sexual function: A 10-year, single-center experience Introduction: Despite increasing consumption rates in much of the world, the impact of cannabis use on various components of male sexual function remain poorly established. The purpose of this study was to further evaluate the relationship between cannabis use and reproductive and sexual […]
Read More
Cannabis, Consciousness, and Healing Wendy Chapkis Federal drug policy defines marijuana as a prohibited Schedule 1 substance—a dangerous drug carrying a high potential for abuse and no accepted medical use. This classification is largely due to the drug’s well‐known psychoactive effects (‘the high’). Because of this, even medical marijuana advocates have tended to downplay the […]
Read More
Exploring New Use of Cannabis Among Older Adults Jennifer Baumbusch, RN, PhD Objectives: In Canada, cannabis prohibition ended in October 2018. Older adults are the fastest growing group of cannabis users and are out-pacing other groups as new users. Clinical evidence indicates that cannabis may be helpful for select medicinal purposes in this population. Yet […]
Read More
Our Courses – Cannabis Education Available Exclusively on our Custom Built LMS We are delighted to have launched our proprietary Learning Management System (LMS). The platform is a turn key solution for qualified educators while also providing high quality courses on a wide range of cannabis related topics. Check it out here Our managed courses […]
Read More
We are hiring! Seeking a GP with Medical Cannabis Focus (Telehealth) – Partnership Opportunity Due to a surge of enquiries to site we are looking to partner with a suitably qualified GP to capitalise on growth opportunities in this exciting new space. About us Our site was first established 5 years ago and we have […]
Read More
Here is a 1 hour lecture of Dr Todd Subritzky’s cannabis focused research. It explores the implementation of the world’s first recreational cannabis market in Colorado and offers solid, evidence based recommendations for policy makers from a public health perspective.
Read More
Three Recent Studies Link Cannabis Use to More Exercise Three recently published studies have associated cannabis use with higher levels of physical activity. Physical activity, sedentary behaviour and cannabis use in 15,822 US adults: cross-sectional analyses from NHANES L Smith, F Sherratt, Y Barnett, C Cao, M A Tully, A Koyanagi, L Jacob, P Soysal, […]
Read More
The long-term efficacy of cannabidiol in the treatment of refractory epilepsy Cannabidiol (CBD) has been shown to reduce seizures among patients with refractory epilepsies of various etiologies in recent clinical trials and an expanded access program (EAP). Most studies report efficacy over short time periods (<1 year), with little published on longer term efficacy. Here, […]
Read More
American Medical Association’s Harmful War on Cannabis Dr Peter Grinspoon writes: The American Medical Association (AMA) has become unmoored in history, seemingly unaware that both racism and the War on Drugs are no longer tolerated by society. A confluence of recent activities and events having to do with their stance on medical cannabis puts them […]
Read More
Buy hemp products and bamboo products online After a Covid enforced hibernation, we are delighted to announce the relaunch of our online store Cool Hemp Stuff. provides high quality bamboo and hemp products from Australia and around the world. We love the versatility of hemp and are proud to offer a wide range of products […]
Read More
Cannabis, Cannabinoids, and Sleep: a Review of the Literature Abstract Purpose of Review The current review aims to summarize the state of research on cannabis and sleep up to 2014 and to review in detail the literature on cannabis and specific sleep disorders from 2014 to the time of publication. Recent Findings Preliminary research into […]
Read More
Cannabis Nausea Study Abstract Goals: We measure for the first time how a wide range of cannabis products affect nausea intensity in actual time. Background: Even though the Cannabis plant has been used to treat nausea for millennia, few studies have measured real-time effects of common and commercially available cannabis-based products. Study: Using the Releaf App, 886 […]
Read More
Despite TGA warnings, most Australian medical cannabis patients still access via the black market The Therapeutic Goods Administration (TGA) is warning consumers about the risks of buying medicinal cannabis products online. In what seems to be an acknowledgement that the vast majority of medical cannabis patients in Australia still access products via the so-called ‘legacy’ […]
Read More
UK CBD Sales Surge Research from two industry pressure groups reveals the UK cannabinoid (CBD) industry was worth £690mln in the 12 months to the end of April – up almost a third since a 2019 estimate. CBD is the non-psychoactive element derived from both marijuana and hemp plants. It is used in an […]
Read More
Epidyolex added to PBS for Dravet Syndrome Press conference about a new treatment on the PBS and Phase 2A of the COVID-19 vaccine rollout Read the transcript of the press conference with Minister Hunt at the Star Health GP Respiratory Clinic at the Prahan Townhall in Melbourne on 30 April about a new treatment for […]
Read More
Medical Cannabis: where are we at? This is a fantastic article by respected experts Associate Professor Vicki Kotsirilos AM was Australia’s first authorised GP prescriber of medicinal cannabis in May 2018. Professor Iain S McGregor is the Academic Director of the Lambert Initiative for Cannabinoid Therapeutics at the University of Sydney’s Brain and Mind Centre. […]
Read More